NT 10-K 1 omega_07kext.htm LATE NOTIFICATION OF FILING FOR 10KSB AT DECEMBER 31, 2007 omega_07kext.htm
 
 

 

 
UNITED STATES
OMB APPROVAL
 
SECURITIES AND EXCHANGE COMMISSION
OMB Number:  3235-0058
   
Expires: April 30, 2009
 
Washington, D.C. 20549
Estimated average burden
   
hours per response  2.50
 
FORM 12b-25
 
   
SEC FILE NUMBER
   
333-51180
 
NOTIFICATION OF LATE FILING
 
     
     

 
(Check One): x Form 10-K  o Form 20-F   o Form 11-K  o Form 10-Q   o Form 10-D     o Form N-SAR  o Form N-CSR

For Period Ended:  December 31, 2007
[   ] Transition Report on Form 10-K
[   ] Transition Report on Form 20-F
[   ] Transition Report on Form 11-K
[   ] Transition Report on Form 10-Q
[   ] Transition Report on Form N-SAR
For the Transition Period Ended:

Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 

PART I -- REGISTRANT INFORMATION
Omega Ventures Group, Inc.
Full Name of Registrant
n/a
Former Name if Applicable
299 South Main Street, Suite 1300
Address of Principal Executive Office (Street and Number)
Salt Lake City, Utah 84111
City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 
(a)      The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
x
(b)      The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
(c)       The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.


 
 

 

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

The annual report of the registrant on Form 10-KSB could not be timely filed because management requires additional time to compile and verify the data required to be included in the report.  The report will be filed within fifteen calendar days of the date the original report was due.

PART IV -- OTHER INFORMATION

(1)
Name and telephone number of person to contact in regard to this notification
 
 
John Rask
 
801
 
 534-4450
 (Name) 
 
(Area Code)
 
 (Telephone Number)

(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s).
                     x Yes¨ No

(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
                     o Yesx No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.



 
 Omega Ventures Group, Inc.
 (Name of Registrant as Specified in Charter)
 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

       
Date: April 1, 2008  
By:
/s/ John Rask  
    John Rask  
     President